$103.86
+0.130 (+0.125%)
At Close: Jun 03, 2026
HC Wainwright Reiterates "Buy" Rating for Insmed (NASDAQ:INSM)
06:48am, Thursday, 06'th Feb 2020
Insmed (NASDAQ:INSM)‘s stock had its “buy” rating restated by equities research analysts at HC Wainwright in a research note issued to investors on Tuesday, TipRanks reports. They currently have
Sign In
Buy INSM